Market Overview

Keryx Prices 6.9M Share Offering at $14.50/Share


Keryx Biopharmaceuticals (NASDAQ: KERX) today announced the pricing of an underwritten public offering of common stock consisting of 6,900,000 shares at $14.50 per share. In connection with this offering, Keryx granted to the underwriters a 30-day option to purchase additional shares of common stock, equal to up to 15% of the number of shares of common stock sold in the offering. Keryx intends to use the net proceeds from the sale of our common stock to fund pre-launch/launch inventory build-up and pre-commercial/commercial activities related to Zerenex, the ongoing development of Zerenex in pre-dialysis, and other general corporate purposes.

See full press release

Posted-In: News Guidance Financing Offerings Management Global


Related Articles (KERX)

View Comments and Join the Discussion!

Partner Center